Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-01-06 @ 8:13 PM
Study NCT ID:
NCT01462695
Status:
COMPLETED
Last Update Posted:
2015-08-27
First Post:
2011-10-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-27
First Submit QC Date:
None
Study First Post Date:
2011-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-02-05
Results First Submit QC Date:
None
Results First Post Date:
2015-03-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-18
Last Update Post Date:
2015-08-27
Last Update Post Date Type:
ESTIMATED